BATTLE-FL: Front-Line Biomarker-Integrated Treatment Study in Non Small Cell Lung Cancer
ImClone LLC
M.D. Anderson Cancer Center

      The goal of this clinical research study is to learn if knowing biomarker status can help
      researchers find better treatment combinations for patients with advanced NSCLC.

      Researchers want to use biomarker status to decide what drug (bevacizumab, or cixutumumab) to
      give in combination with carboplatin and pemetrexed. The safety of these drug combinations
      will also be studied.
    
Drug